Early Predictive Performance of Pre-Endoscopic Risk Scores for Identifying Patients Requiring Endoscopic Therapy in Suspected Non-Variceal Upper Gastrointestinal Bleeding
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S654-S655
DOI: 10.1055/s-0046-1821903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von O Juarez-Leon und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Non-variceal upper gastrointestinal bleeding (NVUGIB) is a frequent emergency requiring early risk stratification to identify patients needing urgent endoscopy and hospitalization. This study evaluated the predictive performance of the AS, modified Glasgow-Blatchford (GBm), AIMS65, and H3B2 scores in suspected NVUGIB [ 1 ] [ 2 ].
Methods
A retrospective observational study included adults undergoing upper endoscopy for suspected NVUGIB between May and December 2024 at Hospital General de México. Clinical, laboratory, and endoscopic data were collected. Pre-endoscopic scores (AS, AIMS65, GBm, H3B2) were calculated. Diagnostic accuracy for predicting endoscopic treatment and hospitalization was assessed using ROC curves and AUC analysis ([ Table 1 ]).
Results
A total of 122 patients were analyzed (63.1% male; mean age 57.7±16.3 years). Melena (54.1%), coffee-ground emesis (25.4%), and hematemesis (16.4%) were the main presenting symptoms. Endoscopic therapy was required in 16.4% of cases, mostly with epinephrine or hemoclips. Gastropathy (40.2%) and peptic ulcer disease (35.3%) were the predominant findings. Hospitalization was required in 38.5% of patients. For predicting endoscopic therapy, the AS score had the highest AUC (0.636; p=0.055), followed by H3B2 (0.629) and AIMS65 (0.615). For hospitalization prediction, GBm (AUC 0.745; p 2, AIMS65>1, H3B2>2, and GBm>6.
Conclusions
The AS score, based on clinical variables available at first contact, showed comparable performance to laboratory-dependent scores—particularly for predicting hospitalization. Its simplicity supports its potential use as a practical triage tool in emergency settings. Further validation could consolidate its role in early NVUGIB management. Table 1 Outcomes Scores AUC (95% CI) P value Cutoff point Sensitivity Specificity Need for endoscopic treatment AS 0.636 (0.502–0.770) 0.055 >2 0.700 0.578 AIMS65 0.615 (0.462–0.768) 0.104 >1 0.700 0.657 H3B2 0.629 (0.509–0.750) 0.068 >2 0.850 0.588 GBm 0.600 (0.483–0.716) 0.159 >7 0.850 0.608 Need for hospitalization AS 0.664 (0.564–0.764) 0.002 >2 0.723 0.520 AIMS65 0.595 (0.492–0.697) 0.079 >1 0.766 0.600 H3B2 0.738 (0.649–0.827) 2 0.830 0.507 GBm 0.745 (0.655–0.836) 6 0.894 0.613 Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Juarez-Leon, O., Torres-Ruíz, M. I., Muñoz-Fuentes, D., Zavala, C. C., Silis, C. C., & Pérez, R. Y. L. (2026). Early Predictive Performance of Pre-Endoscopic Risk Scores for Identifying Patients Requiring Endoscopic Therapy in Suspected Non-Variceal Upper Gastrointestinal Bleeding. Endoscopy, 58(S 03 S 03), S654-S655. https://doi.org/10.1055/s-0046-1821903
Vancouver
Juarez-Leon O, Torres-Ruíz MI, Muñoz-Fuentes D, Zavala CC, Silis CC, Pérez RYL. Early Predictive Performance of Pre-Endoscopic Risk Scores for Identifying Patients Requiring Endoscopic Therapy in Suspected Non-Variceal Upper Gastrointestinal Bleeding. Endoscopy. 2026;58(S 03 S 03):S654-S655. doi:10.1055/s-0046-1821903
BibTeX
@article{JuarezLeon2026,
author = {Juarez-Leon, O and Torres-Ruíz, M I and Muñoz-Fuentes, D and Zavala, CJ C and Silis, CJ C and Pérez, R Y López},
title = {Early Predictive Performance of Pre-Endoscopic Risk Scores for Identifying Patients Requiring Endoscopic Therapy in Suspected Non-Variceal Upper Gastrointestinal Bleeding},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S654--S655},
doi = {10.1055/s-0046-1821903}
}
EUVIMED